Download PDF
Am J Perinatol 2021; 38(07): 676-682
DOI: 10.1055/s-0039-3400308
Original Article

Antenatal Fetal Adrenal Measurements at 22 to 30 Weeks' Gestation, Fetal Growth Restriction, and Perinatal Morbidity

Nathan R. Blue 
1   Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah
,
Matthew Hoffman 
2   Department of Obstetrics and Gynecology, Christiana Care Health System, Wilmington, Delaware
,
Amanda A. Allshouse
1   Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah
,
William A. Grobman
3   Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois
,
Hyagriv N. Simhan
4   Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania
,
Ozhan M. Turan
5   Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland
,
Samuel Parry
6   Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania
,
Judith H. Chung
7   Department of Obstetrics and Gynecology, University of California, Irvine, Orange, California
,
Uma Reddy
8   Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, Yale University, New Haven, Connecticut
,
David M. Haas
9   Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana
,
Stephen Myers
10   Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, Kansas
,
Brian Mercer
11   Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, Ohio
,
George R. Saade
12   Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
,
Robert M. Silver
1   Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah
› Author Affiliations Funding This work was funded by the following NICHD grant awards: U10 HD063020, U10 HD063037, U10 HD063041, U10 HD063046, U10 HD063047, U10 HD063048, U10 HD063053, U10 HD063072, 1K12 HD085816.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Our objective was to test the association of fetal adrenal size with perinatal morbidity among fetuses with fetal growth restriction (FGR; estimated fetal weight [EFW] < 10th percentile).

Study Design This was a secondary analysis of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b) adrenal study, which measured fetal adrenal gland size at 22 to 30 weeks' gestation. We analyzed the transverse adrenal area (TAA) and fetal zone area (absolute measurements and corrected for fetal size) and the ratio of the fetal zone area to the total transverse area using a composite perinatal outcome of stillbirth, neonatal intensive care unit admission, respiratory distress syndrome, necrotizing enterocolitis, retinopathy of prematurity, sepsis, mechanical ventilation, seizure, or death. Among fetuses with FGR, adrenal measurements were compared between those that did and did not experience the composite perinatal outcome.

Results There were 1,709 eligible neonates. Seven percent (n = 120) were diagnosed with FGR at the time of adrenal measurement, and 14.7% (n = 251) experienced perinatal morbidity. EFW-corrected and absolute adrenal measurements were similar among fetuses with and without FGR as well as among those who did and did not experience morbidity. The area under the curve for corrected TAA was 0.52 (95% confidence interval 0.38–0.67).

Conclusion In our cohort, adrenal size was not associated with risk of morbidity among fetuses with FGR.

Keywords

fetal growth restriction - perinatal morbidity - adrenal gland - placental insufficiency - prenatal ultrasound


Publication History

Received: 01 July 2019

Accepted: 30 September 2019

Article published online:
22 November 2019

© 2019. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Jarvis S, Glinianaia SV, Torrioli MG. et al; Surveillance of Cerebral Palsy in Europe (SCPE) collaboration of European Cerebral Palsy Registers. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 2003; 362 (9390): 1106-1111
    CrossrefPubMedGoogle Scholar
  • 2 McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340 (16) 1234-1238
    CrossrefPubMedGoogle Scholar
  • 3 Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341 (8850): 938-941
    CrossrefPubMedGoogle Scholar
  • 4 Crispi F, Miranda J, Gratacós E. Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease. Am J Obstet Gynecol 2018; 218 (2S): S869-S879
    CrossrefPubMedGoogle Scholar
  • 5 Lee ACC, Katz J, Blencowe H. et al; CHERG SGA-Preterm Birth Working Group. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health 2013; 1 (01) e26-e36
    CrossrefPubMedGoogle Scholar
  • 6 Chang TC, Robson SC, Spencer JA, Gallivan S. Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound. Br J Obstet Gynaecol 1994; 101 (05) 422-427
    CrossrefPubMedGoogle Scholar
  • 7 Oros D, Figueras F, Cruz-Martinez R, Meler E, Munmany M, Gratacos E. Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2011; 37 (02) 191-195
    CrossrefPubMedGoogle Scholar
  • 8 Poudel R, McMillen IC, Dunn SL, Zhang S, Morrison JL. Impact of chronic hypoxemia on blood flow to the brain, heart, and adrenal gland in the late-gestation IUGR sheep fetus. Am J Physiol Regul Integr Comp Physiol 2015; 308 (03) R151-R162
    CrossrefPubMedGoogle Scholar
  • 9 Farzad Mohajeri Z, Aalipour S, Sheikh M. et al. Ultrasound measurement of fetal adrenal gland in fetuses with intrauterine growth restriction, an early predictive method for adverse outcomes. J Matern Fetal Neonatal Med 2019; 32 (09) 1485-1491
    CrossrefPubMedGoogle Scholar
  • 10 Heese S, Hammer K, Möllers M. et al. Adrenal gland size in growth restricted fetuses. J Perinat Med 2018; 46 (08) 900-904
    CrossrefPubMedGoogle Scholar
  • 11 Haas DM, Parker CB, Wing DA. et al; NuMoM2b study. A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b). Am J Obstet Gynecol 2015; 212 (04) 539.e1-539.e24
    CrossrefPubMedGoogle Scholar
  • 12 Hoffman MK, Turan OM, Parker CB. et al; Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b) Network. Ultrasound measurement of the fetal adrenal gland as a predictor of spontaneous preterm birth. Obstet Gynecol 2016; 127 (04) 726-734
    CrossrefPubMedGoogle Scholar
  • 13 American College of Obstetricians and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol 2013; 121 (05) 1122-1133
    CrossrefPubMedGoogle Scholar
  • 14 Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3 (01) 32-35
    CrossrefPubMedGoogle Scholar
  • 15 Anderson AB, Laurence KM, Davies K, Campbell H, Turnbull AC. Fetal adrenal weight and the cause of premature delivery in human pregnancy. J Obstet Gynaecol Br Commonw 1971; 78 (06) 481-488
    CrossrefPubMedGoogle Scholar
  • 16 Clifton VL. Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 2010; 31 (Suppl): S33-S39
    CrossrefPubMedGoogle Scholar
  • 17 Huang J, Zhu T, Qu Y, Mu D. Prenatal, perinatal and neonatal risk factors for intellectual disability: a systemic review and meta-analysis. PLoS One 2016; 11 (04) e0153655
    CrossrefPubMedGoogle Scholar